Plain-English translation of NCT06417775 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can prevent migraines that occur during your menstrual cycle. About 496 women will participate across roughly 100 study sites. Researchers want to understand whether this treatment is safe and effective at reducing these period-related migraine attacks.
Many women experience migraines tied to their menstrual cycle, and current treatment options are limited. This study aims to find out if this medication can offer a new way to prevent these predictable migraines before they start.
You would take the study medication (or a placebo) once daily for 7 days starting three days before your expected period, for three consecutive cycles over about 16 weeks. You'll need to visit the clinic regularly for check-ups, blood tests, and side effect monitoring. You'll also track your migraines and symptoms daily using an electronic diary. If the medication appears safe and helpful, you may be invited to continue taking it for an additional 52 weeks in an extension phase.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States